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Background:  Although smoking is a potent risk factor for atherosclerosis, this relationship may not be cumulative and dose-dependent. 
Circulating levels of Pulmonary Surfactant Protein-B (PSAP-B) increase following tobacco-smoke induced damage to the alveolar-capillary membrane 
and may serve as a biomarker of the vascular effects of smoking.
Methods and Results:  Plasma levels of PSAP-B were measured in 3,294 subjects enrolled in the Dallas Heart Study, a probability-based 
population sample. Coronary artery calcium (CAC) was measured by CT, and aortic plaque (AP) by MRI. PSAP-B levels were higher in current vs 
former and never smokers (p<0.001 for trend), and associated with increasing pack-year exposure and smoking frequency (p<0.001 for each). 
In univariable analysis, PSAP-B associated with prevalent CAC (P=0.01) and AP (P<0.0001). In multivariable analysis adjusting for traditional risk 
factors (including smoking exposure), increasing PSAP-B remained associated with aortic plaque (OR 1.18 per SD increment, 95% CI 1.05 to 1.32; 
P=0.01) but not CAC. A significant interaction was observed between PSAP-B, smoking, and AP (pinteraction=0.01), such that higher PSAP-B levels 
independently associated with AP in current smokers, but not in former or never smokers (figure).
Conclusions:  PSAP-B levels increase markedly in association with smoking and independently associate with aortic plaque among smokers, 
supporting a role for PSAP-B as a marker of the vascular effects of tobacco exposure. 
